News

Fri, 16/02/2018
Muenster scientists present their latest research
Muenster.  The Scientific Retreat of the SFB CRC-TR 128 will be held on the 9th and 10th of March 2018. PhD students and young postdocs from all labs of the Department of Neurology and Insititute for Translational Neurology in Münster will give short oral presentations summarizing their main ongoing projects. Sessions will be introduced by […]...more
Fri, 16/02/2018
Ion channels in autoimmune neurodegeneration
Muenster. Autoaggressive T Lymphocytes that have to cross the activated blood brain barrier (BBB) play an important role in the pathogenesis of MS. Prof. Sven Meuth, principal investigator in the DFG-funded cluster of excellence “Cells in Motion” and the CRC 128 “Multiple Sclerosis” focusses on the potassium channel TREK-1. It analyses the molecular pathways through […]...more
Fri, 16/02/2018
Introduction into Histopathology of MS
Muenster, The CRC-128 „Multiple Sclerosis“ offers an histopathology course for its members. The two-day seminar is open for nine selected participants who will get the chance to learn neuropathology techniques and join a microscopy session. Where?: Institute of Neuropathology, Pottkamp 2, 48149 Muenster When?: April 26-27, 2018 flyer histopathology muenster 2018  ...more


Fri, 26/09/2014 | CRC Young Researchers win prizes at prestigious conferences

Congratulations to Dr. Nicholas Schwab and Dr. Tilman Schneider-Hohendorf, both from the Department of Neurology, University of Münster, who received prizes at two prestigious conferences recently!

Nicholas won the MSIF Young Researchers Award for the best presentation of a translational project by a young researcher at the annual congress of the European Committee for Treatment and Research into Multiple Sclerosis (ECTRIMS), which was held jointly with its American counterpart (ACTRIMS) in Boston in September.

Tilman won the Research Prize awarded by the Eva and Helmer Lehmann Foundation at the German Neurological Society conference, also in September, recognizing his recent contribution in the Journal of Experimental Medicine. More information about Tilman’s achievement can be found here (in German).

 

Well done to both of you!